An Evidence-based Staging System for Cutaneous Melanoma
نویسندگان
چکیده
منابع مشابه
Staging of cutaneous melanoma
The American Joint Committee on Cancer (AJCC) staging of cutaneous melanoma is a continuously evolving system. The identification of increasingly more accurate prognostic factors has led to major changes in melanoma staging over the years, and the current system described in this review will likely be modified in the near future. Likewise, application of new imaging techniques has also changed ...
متن کاملThe new melanoma staging system.
The new melanoma staging system from The American Joint Committee on Cancer (AJCC) is described. This major revision includes new criteria for staging the primary tumor (T), metastatic nodes (N) and distant metastases (M) as well as stage groupings. These criteria more accurately reflect those prognostic features of the primary and metastatic melanoma that correlate with survival outcome. Physi...
متن کاملFinal version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
PURPOSE To revise the staging system for cutaneous melanoma under the auspices of the American Joint Committee on Cancer (AJCC). MATERIALS AND METHODS The prognostic factors analysis described in the companion publication (this issue), as well as evidence from the published literature, was used to assemble the tumor-node-metastasis criteria and stage grouping for the melanoma staging system. ...
متن کاملEvidence-based Clinical Practice Guideline: Treatment of Cutaneous Melanoma
INTRODUCTION Rationale and Goals Compared with other cutaneous malignancies, melanoma has the greatest potential for metastasis and, consequently, the highest incidence of mortality. Increased awareness, improved methods of screening, staging, and treatment, and early detection of recurrence are important components of the care continuum that can lead to improved prognosis. Therefore, the aim o...
متن کاملStaging Cutaneous Squamous Cell Carcinoma C REATING A STAGING SYSTEM FOR CANCER
C REATING A STAGING SYSTEM FOR CANCER is not easy. The goal is to stratify patients based on the likelihood of developing an adverse event, most commonly metastasis or death. Groupings should be distinctive (the likelihood of developing the adverse event differs between groups), monotonous (the likelihood increases with increasing stage), and homogeneous (the likelihood is similar within each g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: CA: A Cancer Journal for Clinicians
سال: 2004
ISSN: 0007-9235
DOI: 10.3322/canjclin.54.3.131